Bimeda is pleased to announce the appointment of David Cunningham to the role of Chief Commercial Officer for North America. Cunningham’s appointment is effective from 1st January 2018, and his role will focus on the provision strategic leadership to the US and Canadian business operations.
As a 30 year veteran in animal health, Cunningham brings a wealth of relevant experience to the role, having held an impressive range of high-level assignments in sales, marketing and executive leadership for several leading US animal health companies.
These included the position of Executive Vice President of Sales and Marketing at AgriLabs, Vice President of Sales and Marketing at Boehringer-Inglheim Vetmedica, and President & CEO at Teva Animal Health. For the past three years, he has worked as Chief Operating Officer for Axxiom Consulting; a leading provider of executive consulting services to the animal health industry.
Cunningham commented; “The animal health market is undergoing profound changes in both the livestock and companion animal segments. At this pivotal time for the industry I am excited to join Bimeda and provide strategic leadership to build on Bimeda’s success to date, as well as identifying and capitalizing on new growth opportunities throughout North America’.
Cunningham will report directly to Gavin Tierney, Group Chief Operating Officer & CEO Americas and Europe, who added; ‘Bimeda is on the fast track to becoming a premier provider of animal health and brand alternative products in the United Stated “Dave will be instrumental in guiding our commercial operations to strategically seize new business opportunities.”
Bimeda Inc, North America
Cunningham’s appointment is the latest in a series of significant developments within the Bimeda North America business, and follows on from strategic acquisitions last year within the equine animal health sector. These included the purchase of equine company ArthroDynamic, as well as the acquisition of several prominent equine products from CEVA Animal Health.